Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder.
Hyunjin KimEun-Jae LeeSeungmi KimLyn-Kyung ChoiHyun-Ji KimHye Weon KimKyuyoon ChungDayoung SeoSeongshin MoonKwang-Kuk KimYoung-Min LimPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Among NfL, GFAP, and GFAP/NfL, serum GFAP might be the most appropriate for monitoring NMOSD longitudinally, which warrants future confirming studies.